日本語 / English
news
Announcement on Completion of signing license agreement with NIPPON SHOKUBAI Co., Ltd..
Announcement on Completion of signing license agreement with Nippon Gene Material Co., Ltd.
Japan Healthcare Venture Summit 2022
Notice of publication in the Nikkan Kogyo Shimbun
Notice of publication in Nikkei Biotechnology
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Co., Ltd.
Notice of publication in the magazine "NEW LEADER"
Announcement of selection for an AMED drug discovery basic technology project for the realization of next-generation treatment and diagnosis entitled “Innovative Next Generation of Oligonucleotide Therapeutics (INGOT)”
Japan Healthcare Venture Summit 2021
Japan Healthcare Venture Summit 2020
Notice of participation in Nippon Shokubai Group